Bandingkan Harga & Kinerja Tanah Laut Tbk (INDX) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Tanah Laut Tbk dan Organon Pharma Indonesia Tbk.: Tanah Laut Tbk diperdagangkan di Rp60 (kapitalisasi pasar 26,27 M), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Organon Pharma Indonesia Tbk. jauh lebih besar — sekitar 4× kapitalisasi pasar Tanah Laut Tbk. Mana yang lebih baik tergantung tujuan investasimu.
| INDX | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 26,27 M | 104,4 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Tanah Laut Tbk
PT Tanah Laut Tbk formerly PT Indoexchange Tbk (the Company) was established under the name PT Sanggrahamas Dipta based on Notarial Deed No.78 dated September 19, 1991 of Rahmah Arie Sutarjo, S.H., notary in Jakarta. The Company changed its status from Foreign Capital Investment Company to Domestic Capital Investment Company, approved by the Chairman of Capital Investment Coordinating Board in accordance with Approval Letter No. 38/V/PMDN/2008 dated September 23, 2008.
Selengkapnya di halaman INDX →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
